Navigation Links
Mylan Announces Appointment of Harry A. Korman as President, North America
Date:10/2/2007

PITTSBURGH, Oct. 2 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Harry A. (Hal) Korman to the position of President, North America following the completion of the acquisition of Merck Generics Group today.

In his new role, Mr. Korman will continue to drive growth and development of Mylan Pharmaceuticals Inc. (MPI), Mylan's generics business in the U.S. In addition, he will oversee GenPharm, Inc., the former Canadian subsidiary of Merck Generics and the fourth largest generics company in Canada, and UDL Laboratories, Inc., the U.S. leader in unit dose packaging.

Mr. Korman previously served as President of MPI, as well as Senior Vice President of Mylan Laboratories Inc. Since joining Mylan through its acquisition of UDL Laboratories in 1996, he has served the Company in several capacities of increasing responsibility, including President of UDL and Vice President of Sales and Marketing for MPI.

Mylan Vice Chairman and CEO Robert J. Coury commented: "Hal has played a critical role in our success to date and is a key member of our management team. He has been instrumental in building Mylan into the leader in quality generics in the U.S. that we are today. Since Hal's appointment as President of MPI, he has proven his ability to meet or exceed every objective set for him and he will certainly rise to these new responsibilities. By bringing these North American businesses together under Hal's leadership, we will be best placed to identify and execute on growth and synergy opportunities in the region. I am confident that we will continue to go from strength to strength in North America."

Mr. Korman said: "It's been an honor to be part of Mylan for the last 20 years as the company has grown from a leader in the U.S. to a new global leader in generics and specialty pharmaceuticals. I am also proud to be part of a management team that truly shares one vision for the new Mylan. As we look ahead to the future, there have never been greater opportunities to take the company forward and continue to provide the best quality products and service to our customers."

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.

For more information about Mylan, please visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2018)... ... ... have been doing this for five years. This year’s event takes place on October ... “The Harvest Festival is another way we like to give back to our families in ... Kris and Keith. , The event includes a 50/50 raffle, where half goes to ...
(Date:10/16/2018)... ... October 16, 2018 , ... Balboa Capital , a ... franchise financing , is now recognized by Massage Envy as an Approved ... and deliver custom-tailored financing programs to Massage Envy franchisees who need funding for ...
(Date:10/16/2018)... ... 2018 , ... Bastyr University is pleased announce that Dr. ... Medicine’s (AIHM) Visionary Award for his passionate efforts in forging a new health ... AIHM’s recipient of the Visionary Award due to his tireless effort in naturopathic ...
(Date:10/16/2018)... ... October 16, 2018 , ... dicentra Global Certifications, an ... HACCP Certification Program . Canada will become the first G7 country in the world ... of Canada also plans to formally legalize the production and use of cannabis edibles. ...
(Date:10/16/2018)... , ... October 16, 2018 , ... ... Healthcare Compliance, an attorney experienced in employment law, writes frequently on employment law ... Recently, she authored a chapter in the Health Care Compliance Professional's Manual titled ...
Breaking Medicine News(10 mins):
(Date:10/16/2018)... PHILADELPHIA (PRWEB) , ... October 16, 2018 , ... ... and Expo from October 28-31 at the Pennsylvania Convention Center. At booth 1940, ... based software, biometric devices, mobile app, as well as their specialized Skilled ...
(Date:10/13/2018)... Manchester, UK (PRWEB) , ... October 13, 2018 , ... ... will reach 14.4 per cent over the next five years, from $3200 million in ... a key driver and could even help drive this growth further. This news comes ...
(Date:10/11/2018)... , ... October 11, 2018 , ... In the last ... Europe in two core families and allowance of six more in USA, China and ... the heart of its MRI safety and security products. , The patents assigned from ...
Breaking Medicine Technology: